Financhill
Sell
28

CRSP Quote, Financials, Valuation and Earnings

Last price:
$40.74
Seasonality move :
16.92%
Day range:
$39.41 - $41.02
52-week range:
$39.41 - $91.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.79x
Volume:
3.1M
Avg. volume:
2M
1-year change:
-33.04%
Market cap:
$3.5B
Revenue:
$370M
EPS (TTM):
-$2.80

Earnings Data

Next earnings date for CRSP
Feb 21
2025
Most recent earnings per share
-$1.01
Beat by $0.39
(Nov 5/2024)
Consensus Estimate
-$1.40
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $7.8M -- -- -$1.21 --
11/05/2024 Q3 $7.1M -- -$1.01 -$1.40 $0.39
08/05/2024 Q2 $13.6M -- -$1.49 -$1.42 -$0.07
05/08/2024 Q1 $26.5M -- -$1.43 -$1.46 $0.03
02/21/2024 Q4 $123.1M $200M $1.13 $0.05 $1.08
11/06/2023 Q3 -- -- -$1.41 -$1.95 $0.54
08/07/2023 Q2 -- -- -$0.98 -$2.10 $1.12
05/08/2023 Q1 -- -- -$0.67 -$1.64 $0.97
02/21/2023 Q4 -- -- -$1.41 -$2.27 $0.86
11/01/2022 Q3 -- -- -$2.24 -$2.24 -$0.00
08/08/2022 Q2 -- -- -$2.40 -$2.21 -$0.19
05/09/2022 Q1 -- -- -$2.32 -$1.97 -$0.35
02/16/2022 Q4 -- -- -$1.84 -$1.78 -$0.06
11/03/2021 Q3 -- -- -$1.67 -$1.76 $0.09
07/29/2021 Q2 -- -- $9.44 $3.12 $6.32
04/27/2021 Q1 -- -- -$1.51 -$1.47 -$0.04
02/16/2021 Q4 -- -- -$1.52 -$1.28 -$0.24
10/28/2020 Q3 -- -- -$1.32 -$1.19 -$0.13
07/27/2020 Q2 -- -- -$1.30 -$0.99 -$0.31
04/28/2020 Q1 -- -- -$1.15 -$1.04 -$0.11
02/12/2020 Q4 -- -- $0.51 $0.05 $0.46
10/28/2019 Q3 -- -- $2.40 $1.79 $0.61
07/29/2019 Q2 -- -- -$1.01 -$0.90 -$0.11
04/29/2019 Q1 -- -- -$0.93 -$0.90 -$0.03
02/25/2019 Q4 -- -- -$0.92 -- --
11/07/2018 Q3 -- -- -$1.07 -- --
08/07/2018 Q2 -- -- -$0.82 -- --
05/08/2018 Q1 -- -- -$0.62 -- --
03/08/2018 Q4 -- -- $0.01 -- --
11/08/2017 Q3 -- -- -$0.62 -- --
08/10/2017 Q2 -- -- -$0.56 -- --
03/31/2017 Q1 -- -- -$0.54 -- --
12/31/2016 Q4 -- -- $0.43 -- --
09/30/2016 Q3 -- -- -$0.37 -- --
06/30/2016 Q2 -- -- -$0.43 -- --
03/31/2016 Q1 -- -- -$0.29 -- --
12/31/2015 Q4 -- -- -$0.42 -- --
09/30/2015 Q3 -- -- -$0.22 -- --

CRISPR Therapeutics AG Earnings Questions

  • How Much did CRISPR Therapeutics AG Generate in Revenue Last Quarter?

    CRISPR Therapeutics AG reported -- worth of top line sales in its most recent quarter.

  • Did CRISPR Therapeutics AG Beat Earnings Last Quarter?

    CRISPR Therapeutics AG announced earnings per share of -$1.01 which represents a beat of analyst forecast a -$1.40 per share.

  • Is CRISPR Therapeutics AG Profitable?

    CRISPR Therapeutics AG reported -$11.2M that represents -$0.13 per share over the last quarter.

  • What is the Analyst Consensus for CRISPR Therapeutics AG EPS Next Year?

    CRISPR Therapeutics AG's earnings are forecast to decrease from -$1.94 per share to -$2.95 per share next year representing a decrease of -163.95%.

  • When is CRISPR Therapeutics AG's Earnings Date?

    CRISPR Therapeutics AG's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock